Andre Amorim

Andre Amorim

Andre Amorim
New York
+1 212 459 7352

Andre Amorim is an associate in the firm’s ERISA & Executive Compensation practice and assists with a wide range of compensation and benefits matters. Mr. Amorim advises both public and private companies on tax and securities law issues in connection with mergers and acquisitions, financings, initial public offerings and other corporate transactions. In addition, he regularly advises employers and executives in the negotiation, design and implementation of employment, severance, change in control, deferred compensation, equity and other incentive compensation plans and arrangements.

Representative Matters

  • Integral Health Holdings, LLC, in its acquisition of Courier Therapeutics, Inc. 
  • Collective Medical Technologies, Inc., in its $600 million sale to PointClickCare Corp. 
  • Zoox, Inc. in its sale to Amazon, Inc. (NASDAQ: AMZN).
  • Slack, in its 27.7 billion sale to Salesforce (NYSE: CRM).
  • MyoKardia, in its $13.1 billion sale to Bristol Myers Squibb (NYSE: BMY).
  •, in its $3.2 billion sale to Twilio Inc. (NYSE: TWLO).
  • Vlocity, in its $1.33 billion sale to Salesforce (NYSE: CRM).
  • Moovit, in its approximately $900 million sale to Intel Corporation (NASDAQ: INTC).
  • TA Associates Management, L.P. in its acquisition of AffiniPay Holdings, LLC.
  • Marlin Management Company, in its acquisition of AVI-SPL Acquisition, Inc.
  • Machine Zone, in its sale to AppLovin.
  • TARIS Biomedical, in its sale to Johnson & Johnson.
  • Lime, in a $170 million financing round led by Uber. As part of the deal, Lime acquired Uber's micro-mobility subsidiary Jump.
  • Marlin Equity Partners, in the closing of the sale of Longview to insightsoftware.
  • Hyper Ice in its acquisition of NormaTec Holdings.
  • Surgical Affiliates Management Group, Inc., completed the sale of all of the outstanding equity interests of SAMGI to Varsity Healthcare Partners.
  • CarGurus (NASDAQ: CARG), in its acquisition of Autolist.
  • Sanzaru Games, in its sale to Facebook (NASDAQ: FB).

  • Social Finance, Inc. in its acquisition by Social Capital Hedosophia Holdings V.

  • Galecto, Inc. in its IPO.
  • Cabaletta Bio in its $74 million IPO.
  • AlloVir Inc in its IPO.

Professional Experience

Prior to joining the firm, Mr. Amorim worked in Ernst & Young’s People Advisory Services department where he focused on various executive compensation and employee benefits issues with respect to foreign and domestic equity-based incentive plans, long-term incentive plans, ERISA and Affordable Care Act compliance, and qualified retirement benefit plan matters.




Fordham University School of Law


Fordham University



  • New York